The FDA issued its first stamp of approval for a cell or gene therapy back in 2017 to Novartis' Kymriah. | The gene therapy ...

Insurer access challenges likely lie ahead for the novel schizophrenia drug Cobenfy, given its considerably higher price than ...

Cobenfy also contains trospium, which blocks some of the side effects. The most common are nausea, vomiting and indigestion.

Some people who took a new schizophrenia drug for a year improved with only a few side effects, but many dropped out of the research, the company announced Thursday. The results underscore the ...

Ironically, a new TikTok trend has emerged to prevent you from partaking in this past time — a “dopamine menu.” This is a list consisting of various activities to get you off your screen ...

The Central Drug Regulatory Authority has identified four drugs, including popular calcium supplement Shelcal 500 and Pan D, as spurious. Additionally, 49 drug samples were deemed "Not of Standard ...

The purpose of displaying the NSQ list is to make stakeholders aware about the NSQ batches identified in the market, the drug regulator stated. (Image Credits: Pixabay) The Central Drugs Standard ...

Federal officials have celebrated a striking drop in drug overdoses across the country. But state-level data shows that Black people are suffering significantly worse outcomes than white people.

These newly discovered pathways connect to dopamine-producing neurons in the brain — one stimulates dopamine release and the other inhibits it. By controlling the amount of dopamine in the brain via ...

For the drugs selected under the rebate program, CMS estimates that beneficiaries will receive coinsurance savings of as much as $1 to $3,854 per day. The list of drugs selected for the rebate ...

“is the first antipsychotic drug approved to treat schizophrenia that targets cholinergic receptors as opposed to dopamine receptors, which has long been the standard of care,” the FDA said in ...